カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のゲノムベース薬市場2022年：インスリン、成長ホルモン、モノクローナル抗体、その他

◆英語タイトル：Global Genome-Based Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8832 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ゲノムベース薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のゲノムベース薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ゲノムベース薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・インスリン、成長ホルモン、モノクローナル抗体、その他

用途別セグメントは次のように区分されます。
・病院、製薬工場、その他

世界のゲノムベース薬市場の主要な市場プレーヤーは以下のとおりです。
・Sandoz International、Teva pharmaceutical industries、Mylan、3SBio、Shanghai Fosun Pharmaceutical、Tonghua Dongbao Pharmaceutical、Biocon、Reliance Life Sciences、Probiomed、Biosidus、AMEGA Biotech、Celltrion、LG Life Science、Dong-A Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ゲノムベース薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なゲノムベース薬メーカーの企業概要、2019年～2022年までのゲノムベース薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なゲノムベース薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ゲノムベース薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのゲノムベース薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのゲノムベース薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびゲノムベース薬の産業チェーンを掲載しています。
・第13、14、15章では、ゲノムベース薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sandoz International、Teva pharmaceutical industries、Mylan、3SBio、Shanghai Fosun Pharmaceutical、Tonghua Dongbao Pharmaceutical、Biocon、Reliance Life Sciences、Probiomed、Biosidus、AMEGA Biotech、Celltrion、LG Life Science、Dong-A Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：インスリン、成長ホルモン、モノクローナル抗体、その他
・用途別分析2017年-2028年：病院、製薬工場、その他
・ゲノムベース薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ゲノムベース薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ゲノムベース薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ゲノムベース薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ゲノムベース薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Genome-Based Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genome-Based Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Genome-Based Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Genome-Based Drug include Sandoz International, Teva pharmaceutical industries, Mylan, 3SBio, and Shanghai Fosun Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genome-Based Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin
Growth Hormone
Monoclonal Antibody
Other
Market segment by Application can be divided into
Hospital
Pharmaceutical Factory
Other
The key market players for global Genome-Based Drug market are listed below:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance Life Sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG Life Science
Dong-A Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Genome-Based Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Genome-Based Drug, with price, sales, revenue and global market share of Genome-Based Drug from 2019 to 2022.
Chapter 3, the Genome-Based Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genome-Based Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Genome-Based Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genome-Based Drug.
Chapter 13, 14, and 15, to describe Genome-Based Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Genome-Based Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genome-Based Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Insulin
1.2.3 Growth Hormone
1.2.4 Monoclonal Antibody
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Genome-Based Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Other
1.4 Global Genome-Based Drug Market Size & Forecast
1.4.1 Global Genome-Based Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Genome-Based Drug Sales in Volume (2017-2028)
1.4.3 Global Genome-Based Drug Price (2017-2028)
1.5 Global Genome-Based Drug Production Capacity Analysis
1.5.1 Global Genome-Based Drug Total Production Capacity (2017-2028)
1.5.2 Global Genome-Based Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Genome-Based Drug Market Drivers
1.6.2 Genome-Based Drug Market Restraints
1.6.3 Genome-Based Drug Trends Analysis
2 Manufacturers Profiles
2.1 Sandoz International
2.1.1 Sandoz International Details
2.1.2 Sandoz International Major Business
2.1.3 Sandoz International Genome-Based Drug Product and Services
2.1.4 Sandoz International Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva pharmaceutical industries
2.2.1 Teva pharmaceutical industries Details
2.2.2 Teva pharmaceutical industries Major Business
2.2.3 Teva pharmaceutical industries Genome-Based Drug Product and Services
2.2.4 Teva pharmaceutical industries Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Genome-Based Drug Product and Services
2.3.4 Mylan Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 3SBio
2.4.1 3SBio Details
2.4.2 3SBio Major Business
2.4.3 3SBio Genome-Based Drug Product and Services
2.4.4 3SBio Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shanghai Fosun Pharmaceutical
2.5.1 Shanghai Fosun Pharmaceutical Details
2.5.2 Shanghai Fosun Pharmaceutical Major Business
2.5.3 Shanghai Fosun Pharmaceutical Genome-Based Drug Product and Services
2.5.4 Shanghai Fosun Pharmaceutical Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tonghua Dongbao Pharmaceutical
2.6.1 Tonghua Dongbao Pharmaceutical Details
2.6.2 Tonghua Dongbao Pharmaceutical Major Business
2.6.3 Tonghua Dongbao Pharmaceutical Genome-Based Drug Product and Services
2.6.4 Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business
2.7.3 Biocon Genome-Based Drug Product and Services
2.7.4 Biocon Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Reliance Life Sciences
2.8.1 Reliance Life Sciences Details
2.8.2 Reliance Life Sciences Major Business
2.8.3 Reliance Life Sciences Genome-Based Drug Product and Services
2.8.4 Reliance Life Sciences Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Probiomed
2.9.1 Probiomed Details
2.9.2 Probiomed Major Business
2.9.3 Probiomed Genome-Based Drug Product and Services
2.9.4 Probiomed Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Biosidus
2.10.1 Biosidus Details
2.10.2 Biosidus Major Business
2.10.3 Biosidus Genome-Based Drug Product and Services
2.10.4 Biosidus Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AMEGA Biotech
2.11.1 AMEGA Biotech Details
2.11.2 AMEGA Biotech Major Business
2.11.3 AMEGA Biotech Genome-Based Drug Product and Services
2.11.4 AMEGA Biotech Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion Genome-Based Drug Product and Services
2.12.4 Celltrion Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 LG Life Science
2.13.1 LG Life Science Details
2.13.2 LG Life Science Major Business
2.13.3 LG Life Science Genome-Based Drug Product and Services
2.13.4 LG Life Science Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dong-A Pharmaceutical
2.14.1 Dong-A Pharmaceutical Details
2.14.2 Dong-A Pharmaceutical Major Business
2.14.3 Dong-A Pharmaceutical Genome-Based Drug Product and Services
2.14.4 Dong-A Pharmaceutical Genome-Based Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Genome-Based Drug Breakdown Data by Manufacturer
3.1 Global Genome-Based Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Genome-Based Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Genome-Based Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Genome-Based Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Genome-Based Drug Manufacturer Market Share in 2021
3.5 Global Genome-Based Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Genome-Based Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Genome-Based Drug Market Size by Region
4.1.1 Global Genome-Based Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Genome-Based Drug Revenue by Region (2017-2028)
4.2 North America Genome-Based Drug Revenue (2017-2028)
4.3 Europe Genome-Based Drug Revenue (2017-2028)
4.4 Asia-Pacific Genome-Based Drug Revenue (2017-2028)
4.5 South America Genome-Based Drug Revenue (2017-2028)
4.6 Middle East and Africa Genome-Based Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Genome-Based Drug Sales in Volume by Type (2017-2028)
5.2 Global Genome-Based Drug Revenue by Type (2017-2028)
5.3 Global Genome-Based Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Genome-Based Drug Sales in Volume by Application (2017-2028)
6.2 Global Genome-Based Drug Revenue by Application (2017-2028)
6.3 Global Genome-Based Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Genome-Based Drug Sales by Type (2017-2028)
7.2 North America Genome-Based Drug Sales by Application (2017-2028)
7.3 North America Genome-Based Drug Market Size by Country
7.3.1 North America Genome-Based Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Genome-Based Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Genome-Based Drug Sales by Type (2017-2028)
8.2 Europe Genome-Based Drug Sales by Application (2017-2028)
8.3 Europe Genome-Based Drug Market Size by Country
8.3.1 Europe Genome-Based Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Genome-Based Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Genome-Based Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Genome-Based Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Genome-Based Drug Market Size by Region
9.3.1 Asia-Pacific Genome-Based Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Genome-Based Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Genome-Based Drug Sales by Type (2017-2028)
10.2 South America Genome-Based Drug Sales by Application (2017-2028)
10.3 South America Genome-Based Drug Market Size by Country
10.3.1 South America Genome-Based Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Genome-Based Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Genome-Based Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Genome-Based Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Genome-Based Drug Market Size by Country
11.3.1 Middle East & Africa Genome-Based Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Genome-Based Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Genome-Based Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Genome-Based Drug
12.3 Genome-Based Drug Production Process
12.4 Genome-Based Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Genome-Based Drug Typical Distributors
13.3 Genome-Based Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Genome-Based Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Genome-Based Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 4. Sandoz International Major Business
Table 5. Sandoz International Genome-Based Drug Product and Services
Table 6. Sandoz International Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva pharmaceutical industries Basic Information, Manufacturing Base and Competitors
Table 8. Teva pharmaceutical industries Major Business
Table 9. Teva pharmaceutical industries Genome-Based Drug Product and Services
Table 10. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Genome-Based Drug Product and Services
Table 14. Mylan Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. 3SBio Basic Information, Manufacturing Base and Competitors
Table 16. 3SBio Major Business
Table 17. 3SBio Genome-Based Drug Product and Services
Table 18. 3SBio Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Shanghai Fosun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Shanghai Fosun Pharmaceutical Major Business
Table 21. Shanghai Fosun Pharmaceutical Genome-Based Drug Product and Services
Table 22. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Tonghua Dongbao Pharmaceutical Major Business
Table 25. Tonghua Dongbao Pharmaceutical Genome-Based Drug Product and Services
Table 26. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Biocon Basic Information, Manufacturing Base and Competitors
Table 28. Biocon Major Business
Table 29. Biocon Genome-Based Drug Product and Services
Table 30. Biocon Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Reliance Life Sciences Major Business
Table 33. Reliance Life Sciences Genome-Based Drug Product and Services
Table 34. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Probiomed Basic Information, Manufacturing Base and Competitors
Table 36. Probiomed Major Business
Table 37. Probiomed Genome-Based Drug Product and Services
Table 38. Probiomed Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Biosidus Basic Information, Manufacturing Base and Competitors
Table 40. Biosidus Major Business
Table 41. Biosidus Genome-Based Drug Product and Services
Table 42. Biosidus Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AMEGA Biotech Basic Information, Manufacturing Base and Competitors
Table 44. AMEGA Biotech Major Business
Table 45. AMEGA Biotech Genome-Based Drug Product and Services
Table 46. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Celltrion Basic Information, Manufacturing Base and Competitors
Table 48. Celltrion Major Business
Table 49. Celltrion Genome-Based Drug Product and Services
Table 50. Celltrion Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. LG Life Science Basic Information, Manufacturing Base and Competitors
Table 52. LG Life Science Major Business
Table 53. LG Life Science Genome-Based Drug Product and Services
Table 54. LG Life Science Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Dong-A Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Dong-A Pharmaceutical Major Business
Table 57. Dong-A Pharmaceutical Genome-Based Drug Product and Services
Table 58. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Genome-Based Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 60. Global Genome-Based Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Genome-Based Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Genome-Based Drug Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 63. Head Office and Genome-Based Drug Production Site of Key Manufacturer
Table 64. Genome-Based Drug New Entrant and Capacity Expansion Plans
Table 65. Genome-Based Drug Mergers & Acquisitions in the Past Five Years
Table 66. Global Genome-Based Drug Sales by Region (2017-2022) & (Kiloton)
Table 67. Global Genome-Based Drug Sales by Region (2023-2028) & (Kiloton)
Table 68. Global Genome-Based Drug Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Genome-Based Drug Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 71. Global Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 72. Global Genome-Based Drug Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Genome-Based Drug Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Genome-Based Drug Price by Type (2017-2022) & (US$/Ton)
Table 75. Global Genome-Based Drug Price by Type (2023-2028) & (US$/Ton)
Table 76. Global Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 77. Global Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 78. Global Genome-Based Drug Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Genome-Based Drug Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Genome-Based Drug Price by Application (2017-2022) & (US$/Ton)
Table 81. Global Genome-Based Drug Price by Application (2023-2028) & (US$/Ton)
Table 82. North America Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)
Table 83. North America Genome-Based Drug Sales by Country (2023-2028) & (Kiloton)
Table 84. North America Genome-Based Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Genome-Based Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 87. North America Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 88. North America Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 89. North America Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 90. Europe Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)
Table 91. Europe Genome-Based Drug Sales by Country (2023-2028) & (Kiloton)
Table 92. Europe Genome-Based Drug Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Genome-Based Drug Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 95. Europe Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 96. Europe Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 97. Europe Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 98. Asia-Pacific Genome-Based Drug Sales by Region (2017-2022) & (Kiloton)
Table 99. Asia-Pacific Genome-Based Drug Sales by Region (2023-2028) & (Kiloton)
Table 100. Asia-Pacific Genome-Based Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Genome-Based Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 103. Asia-Pacific Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 104. Asia-Pacific Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 105. Asia-Pacific Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 106. South America Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)
Table 107. South America Genome-Based Drug Sales by Country (2023-2028) & (Kiloton)
Table 108. South America Genome-Based Drug Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Genome-Based Drug Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 111. South America Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 112. South America Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 113. South America Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 114. Middle East & Africa Genome-Based Drug Sales by Region (2017-2022) & (Kiloton)
Table 115. Middle East & Africa Genome-Based Drug Sales by Region (2023-2028) & (Kiloton)
Table 116. Middle East & Africa Genome-Based Drug Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Genome-Based Drug Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)
Table 119. Middle East & Africa Genome-Based Drug Sales by Type (2023-2028) & (Kiloton)
Table 120. Middle East & Africa Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)
Table 121. Middle East & Africa Genome-Based Drug Sales by Application (2023-2028) & (Kiloton)
Table 122. Genome-Based Drug Raw Material
Table 123. Key Manufacturers of Genome-Based Drug Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Genome-Based Drug Typical Distributors
Table 127. Genome-Based Drug Typical Customers
List of Figures
Figure 1. Genome-Based Drug Picture
Figure 2. Global Genome-Based Drug Revenue Market Share by Type in 2021
Figure 3. Insulin
Figure 4. Growth Hormone
Figure 5. Monoclonal Antibody
Figure 6. Other
Figure 7. Global Genome-Based Drug Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Pharmaceutical Factory
Figure 10. Other
Figure 11. Global Genome-Based Drug Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 12. Global Genome-Based Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Genome-Based Drug Sales (2017-2028) & (Kiloton)
Figure 14. Global Genome-Based Drug Price (2017-2028) & (US$/Ton)
Figure 15. Global Genome-Based Drug Production Capacity (2017-2028) & (Kiloton)
Figure 16. Global Genome-Based Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Genome-Based Drug Market Drivers
Figure 18. Genome-Based Drug Market Restraints
Figure 19. Genome-Based Drug Market Trends
Figure 20. Global Genome-Based Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Genome-Based Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Genome-Based Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Genome-Based Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Genome-Based Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Genome-Based Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Genome-Based Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Genome-Based Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Genome-Based Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Genome-Based Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Genome-Based Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Genome-Based Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Genome-Based Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Genome-Based Drug Price by Type (2017-2028) & (US$/Ton)
Figure 35. Global Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Genome-Based Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Genome-Based Drug Price by Application (2017-2028) & (US$/Ton)
Figure 38. North America Genome-Based Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Genome-Based Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Genome-Based Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Genome-Based Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Genome-Based Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Genome-Based Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Genome-Based Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Genome-Based Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Genome-Based Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Genome-Based Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Genome-Based Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Genome-Based Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Genome-Based Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Genome-Based Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Genome-Based Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Genome-Based Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Genome-Based Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Genome-Based Drug in 2021
Figure 79. Manufacturing Process Analysis of Genome-Based Drug
Figure 80. Genome-Based Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のゲノムベース薬市場2022年：インスリン、成長ホルモン、モノクローナル抗体、その他(Global Genome-Based Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のゲノムベース薬市場2022年：インスリン、成長ホルモン、モノクローナル抗体、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp